DIA
Drug Information Association Logo

CURRENT STATUS AND FUTURE CHALLENGES OF ASIAN REGULATORY ENVIRONMENT

Track:
Globalisation/Inspections

Day & Time:
March 27, 2:00PM - 3:30PM (Central European Standard Time)

Session Number:
1007

Room Number:
Room LM

Type:
Session

Title:
CURRENT STATUS AND FUTURE CHALLENGES OF ASIAN REGULATORY ENVIRONMENT

Chair(s):
Nobumasa Nakashima, PhD
International Planning Director (Pharmaceutical Affairs), Ministers Affairs
Ministry of Health, Labour and Welfare (MHLW) , Japan

Description:
The Asian region is becoming a pharmaceutical manufacturing hub as well as a key market. This session will clarify current issues and discuss future direction in promoting regulatory harmonisation in Asia, focusing on ICH, APEC and ASEAN.

Presentation(s) & Speaker(s):
Update from Thailand
Yuppadee Javroongrit, PhD
Senior Expert in Pharmaceuticals Standard
Food and Drug Administration, MOPH, Thailand

Update from Korea
Moo-Young Yoo, MPharm, RPh
Director, Pharmaceutical Safety Policy Division
Korean Food and Drug Administration (KFDA) , Korea, Republic of

Update from China
Jinhai Qiu
Division Chief
Information Center of China Food and Drug Administration (CFDA), China

Update from Japan
Hiroshi Yamamoto, MS
Chief Safety Officer
Pharmaceuticals and Medical Devices Agency (PMDA), Japan